Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1975 Dec;12(6):1375–1385. doi: 10.1128/iai.12.6.1375-1385.1975

Production and properties of an extracellular bacteriocin from Streptococcus mutans bacteriocidal for group A and other streptococci.

D Paul, H D Slade
PMCID: PMC415445  PMID: 1107225

Abstract

An extracellular bacteriocidal substance is produced by a serotype c strain of Streptococcus mutans in liquid meduim during the stationary phase of growth. The lethal effect of the substance was demonstrated by the decrease in viable counts of a standardized suspension of group A streptococci in broth. No lysis of affected cells was observed and no changes in appearance of these cells was seen in electron micrographs. The material was effective against certain strains of immmunological groups A, C, D, G, H, L, and O streptococci. It was inactive against strains of S. mutans belonging to the a, b, c, and d serotypes, Bacillus subtilis, Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. The factor was purified 273-fold from the culture fluid by column chromatography. It was sensitive to trysin and Pronase and resistant to catalase. It possessed a molecular weight of more than 20,000 and was not dialyzable. The properties of this substance indicate that it is a bacteriocin. Group A streptococci, which had been treated with antiserum specific for the cell wall group and type antigens, were susceptible to the bacteriocin. Streptococcal strains resistant to the lethal action of the bacteriocin adsorbed the bacteriocin from the solutions, as did the sensitive cells. The bacteriocin was not adsorbed at 0 C.

Full text

PDF
1375

Images in this article

1379Image
on p.1379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROCK T. D., DAVIE J. M. PROBABLE IDENTITY OF A GROUP D HEMOLYSIN WITH A BACTERIOCINE. J Bacteriol. 1963 Oct;86:708–712. doi: 10.1128/jb.86.4.708-712.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BROCK T. D., PEACHER B., PIERSON D. SURVEY OF THE BACTERIOCINES OF ENTEROCOCCI. J Bacteriol. 1963 Oct;86:702–707. doi: 10.1128/jb.86.4.702-707.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bazaral M., Helinski D. R. Circular DNA forms of colicinogenic factors E1, E2 and E3 from Escherichia coli. J Mol Biol. 1968 Sep 14;36(2):185–194. doi: 10.1016/0022-2836(68)90374-4. [DOI] [PubMed] [Google Scholar]
  4. Boon T. Inactivation of ribosomes in vitro by colicin E 3 . Proc Natl Acad Sci U S A. 1971 Oct;68(10):2421–2425. doi: 10.1073/pnas.68.10.2421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bratthall D. Demonstration of five serological groups of streptococcal strains resembling Streptococcus mutans. Odontol Revy. 1970;21(2):143–152. [PubMed] [Google Scholar]
  6. Dajani A. S., Wannamaker L. W. Demonstration of a bactericidal substance against beta-hemolytic streptococci in supernatant fluids of staphylococcal cultures. J Bacteriol. 1969 Mar;97(3):985–991. doi: 10.1128/jb.97.3.985-991.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dajani A. S., Wannamaker L. W. Kinetic studies on the interaction of bacteriophage type 71 staphylococcal bacteriocin with susceptible bacteria. J Bacteriol. 1973 May;114(2):738–742. doi: 10.1128/jb.114.2.738-742.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FREDERICQ P. Colicins. Annu Rev Microbiol. 1957;11:7–22. doi: 10.1146/annurev.mi.11.100157.000255. [DOI] [PubMed] [Google Scholar]
  9. Hale E. M., Hinsdill R. D. Biological activity of staphylococcin 162: bacteriocin from Staphylococcus aureus. Antimicrob Agents Chemother. 1975 Jan;7(1):74–81. doi: 10.1128/aac.7.1.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hamada S., Ooshima T. Inhibitory spectrum of a bacteriocinlike substance (mutacin) produced by some strains of Streptococcus mutans. J Dent Res. 1975 Jan-Feb;54(1):140–145. doi: 10.1177/00220345750540010801. [DOI] [PubMed] [Google Scholar]
  11. Holmberg K., Hallander H. O. Production of bactericidal concentrations of hydrogen peroxide by Streptococcus sanguis. Arch Oral Biol. 1973 Mar;18(3):423–434. doi: 10.1016/0003-9969(73)90167-2. [DOI] [PubMed] [Google Scholar]
  12. Ivanovics G. BACTERIOCINS AND BACTERIOCIN-LIKE SUBSTANCES. Bacteriol Rev. 1962 Jun;26(2 Pt 1):108–118. [PMC free article] [PubMed] [Google Scholar]
  13. Jetten A. M., Vogels G. D. Characteristics of the killing effect of a Staphylococcus epidermidis bacteriocin. Antonie Van Leeuwenhoek. 1974;40(1):177–183. doi: 10.1007/BF00394565. [DOI] [PubMed] [Google Scholar]
  14. Jetten A. M., Vogels G. D., de Windt F. Production and purification of a Staphylococcus epidermidis bacteriocin. J Bacteriol. 1972 Oct;112(1):235–242. doi: 10.1128/jb.112.1.235-242.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kelstrup J., Gibbons R. J. Bacteriocins from human and rodent streptococci. Arch Oral Biol. 1969 Mar;14(3):251–258. doi: 10.1016/0003-9969(69)90227-1. [DOI] [PubMed] [Google Scholar]
  16. Krämer J., Brandis H. Charakterisierung eines Streptococcus agalactiae-Bacteriocins. Zentralbl Bakteriol Orig A. 1972 Mar;219(3):290–301. [PubMed] [Google Scholar]
  17. Kuttner A. G. Production of bacteriocines by group A streptococci with special reference to the nephritogenic types. J Exp Med. 1966 Sep 1;124(3):279–291. doi: 10.1084/jem.124.3.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  19. LURIA S. E. ON THE MECHANISMS OF ACTION OF COLICINS. Ann Inst Pasteur (Paris) 1964 Nov;107:SUPPL–SUPPL:73. [PubMed] [Google Scholar]
  20. Maeda A., Nomura M. Interaction of colicins with bacterial cells. I. Studies with radioactive colicins. J Bacteriol. 1966 Feb;91(2):685–694. doi: 10.1128/jb.91.2.685-694.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Malke H., Starke R., Jacob H. E., Köhler W. Bacteriocine-like activity of group-A streptococci due to the production of peroxide. J Med Microbiol. 1974 Aug;7(3):367–374. doi: 10.1099/00222615-7-3-367. [DOI] [PubMed] [Google Scholar]
  22. Nomura M. Colicins and related bacteriocins. Annu Rev Microbiol. 1967;21:257–284. doi: 10.1146/annurev.mi.21.100167.001353. [DOI] [PubMed] [Google Scholar]
  23. Overturf G. D., Mortimer E. A., Jr Studies of the relationship between the production of bacteriocines by group A streptococci and acute glomerulonephritis. J Exp Med. 1970 Oct 1;132(4):694–701. doi: 10.1084/jem.132.4.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Perry D. Transformability of streptomycin-resistant group H streptococci. J Bacteriol. 1968 Jan;95(1):132–138. doi: 10.1128/jb.95.1.132-138.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. REEVES P. THE BACTERIOCINS. Bacteriol Rev. 1965 Mar;29:24–45. doi: 10.1128/br.29.1.24-45.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rogers A. H. Effect of the medium on bacteriocin production among strains of Streptococcus mutans. Appl Microbiol. 1972 Aug;24(2):294–295. doi: 10.1128/am.24.2.294-295.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rogul M., Carr S. R. Variable ammonia production among smooth and rough strains of Pseudomonas pseudomallei: resemblance to bacteriocin production. J Bacteriol. 1972 Oct;112(1):372–380. doi: 10.1128/jb.112.1.372-380.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Scherp H. W. Dental caries: prospects for prevention. Science. 1971 Sep 24;173(4003):1199–1205. doi: 10.1126/science.173.4003.1199. [DOI] [PubMed] [Google Scholar]
  29. Schlegel R., Slade H. D. Alteration of macromolecular synthesis and membrane permeability by a Streptococcus sanguis bacteriocin. J Gen Microbiol. 1974 Mar;81(1):275–277. doi: 10.1099/00221287-81-1-275. [DOI] [PubMed] [Google Scholar]
  30. Schlegel R., Slade H. D. Bacteriocin production by transformable group H streptococci. J Bacteriol. 1972 Nov;112(2):824–829. doi: 10.1128/jb.112.2.824-829.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tagg J. R., Dajani A. S., Wannamaker L. W., Gray E. D. Group A streptococcal bacteriocin. Production, purification, and mode of action. J Exp Med. 1973 Nov 1;138(5):1168–1183. doi: 10.1084/jem.138.5.1168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tagg J. R., Read R. S., McGiven A. R. Bacteriocin of a group A streptococcus: partial purification and properties. Antimicrob Agents Chemother. 1973 Sep;4(3):214–221. doi: 10.1128/aac.4.3.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tzannetis S., Poulaki-Tsontou A., Papavassiliou J. Bacteriocine production in group B streptococci. Pathol Microbiol (Basel) 1974;41(1):51–57. doi: 10.1159/000162563. [DOI] [PubMed] [Google Scholar]
  34. Wolff L. F., Duncan J. L. Studies on a bactericidal substance produced by group A streptococci. J Gen Microbiol. 1974 Apr;81(2):413–424. doi: 10.1099/00221287-81-2-413. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES